My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 11 743 / DOI: 10.3332/ecancer.2017.743

Special Issue

The Veronesi quadrantectomy: an historical overview

Following a clinical trial in which the Halsted mastectomy was compared to the less invasive quadrantectomy, no differences were reported in terms of local recurrence, disease-free or overall survival between the two. As a result, Umberto Veronesi was the first in the world to state that the radical mastectomy appeared to involve unnecessary mutilation in patients with breast cancer of less than 2 cm and no palpable axillary nodes.

To date, the Veronesi quadrantectomy is routinely considered for breast cancer treatment. This brief review, which highlights the main advances over the last 50 years, is dedicated to Professor Umberto Veronesi.

Keywords: breast cancer, conservative treatment, mastectomy, axillary dissection, radiotherapy

Loading Article Metrics ... Please wait

Related articles

Research: A discrete transition zone between cuticle and cortex layers of a human hair fibre: changes observed in the presence of breast cancer

Abstract | Full Article | PDF Published: 13 Oct 2017 / DOI: 10.3332/ecancer.2017.772

Conference Report: Highlights from the WIN 2017 Symposium, 26–27 June 2017, Paris, France: ‘Expediting Global Innovation in Precision Cancer Medicine’

Abstract | Full Article | PDF Published: 27 Sep 2017 / DOI: 10.3332/ecancer.2017.770

Research: Limitations of workers diagnosed with cancer evaluated with Work Role Functioning Questionnaire-Br

Abstract | Full Article | PDF | Portuguese Published: 18 Sep 2017 / DOI: 10.3332/ecancer.2017.769

Review: Proteins regulating the intercellular transfer and function of P-glycoprotein in multidrug-resistant cancer

Abstract | Full Article | PDF Published: 18 Sep 2017 / DOI: 10.3332/ecancer.2017.768

Case Report: Unusual case of splenic sarcoidosis without morphological lesions detected by PET-CT in a patient with breast cancer: functional imaging between pitfalls and therapeutic guide

Abstract | Full Article | PDF Published: 08 Sep 2017 / DOI: 10.3332/ecancer.2017.766



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence